Across TCGA pan-cancer cohorts, TOMM7 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TOMM7 data layer compared with 23 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TOMM7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TOMM7 expression acts as an unfavorable survival marker.

COAD, THYM, and PRAD are the cancer types where TOMM7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.054	0.871	<.001	24	view →
THYM	OS	Median	All	0.186	0.931	<.001	15	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: TOMM7 tumor-vs-normal RNA expression · all TOMM7 data types